Our customers' Feedback
Search:
Perform search
Categories list

Generic Efavirenz

News
Efavirenz
Efavirenz photo

Generic Efavirenz (Efavirenz)

HIV

PackagePricePer PillSavingsOrder
200mg × 30 pills$130.00$4.33Add to cart
200mg × 60 pills$230.00$3.83$30.00Add to cart
200mg × 90 pills$315.00$3.50$75.00Add to cart

PackagePricePer PillSavingsOrder
500mg × 10 pills$93.30$9.33Add to cart
500mg × 20 pills$176.50$8.82$10.10Add to cart
500mg × 30 pills$250.00$8.33$29.90Add to cart

PackagePricePer PillSavingsOrder
600mg × 10 pills$100.00$10.00Add to cart
600mg × 20 pills$190.00$9.50$10.00Add to cart

Most popular quantity.
Epivir
$ 1.73
Generic Epivir
(Lamivudine 100/150mg)
Famvir
$ 3.00
Generic Famvir
(Famciclovir 250mg)
Norvir
$ 5.00
Generic Norvir
(Ritonavir 100mg)
Retrovir
$ 1.17
Generic Retrovir
(Zidovudine 100/300mg)
Truvada
$ 5.55
Generic Truvada
(Tenofovir Emtricitabine 300mg + 200mg)
Viread
$ 4.44
Generic Viread
(Tenofovir Disoproxil Fumarate 300mg)
Social bookmarks:
Choose your language:



Money backguarantee
Secureshopping

Our billing is certified by:

Secure shopping certificates

Special Offer!

  • Small doses of anti-HIV drug efavirenz might treat Alzheimer's - Drug Target Review

    Drug Target ReviewSmall doses of anti-HIV drug efavirenz might treat Alzheimer'sDrug Target ReviewThe target pinpointed by the NIST scientists is where an approved anti-HIV drug – efavirenz – latches to the enzyme already responsible for about 80 percent of the cholesterol elimination from the human brain.

  • Hiv, rilpivirina/tenofovir/emtricitabina non inferiore a efavirenz/tenofovir/emtricitabina - PharmaStar

    PharmaStarHiv, rilpivirina/tenofovir/emtricitabina non inferiore a efavirenz/tenofovir/emtricitabinaPharmaStarUno studio testa a testa tra due combinazioni a dose fissa di farmaci antiretrovirali ha dimostrato la non inferiorità di rilpivirina/tenofovir/emtricitabina (Complera), rispetto alla terapia standard con efavirenz/tenofovir/emtricitabina (Atripla), in .

  • HIV: Complera Non-Inferior to Atripla - MedPage Today

    HIV: Complera Non-Inferior to AtriplaMedPage TodayDURBAN, South Africa – A head-to-head comparison of two single-tablet combinations appears to position rilpivirine plus tenofovir and emtricitabine (Complera) as an option for treatment alongside standard-of-care efavirenz plus tenofovir and .

  • Once-Daily Dolutegravir Regimen Assists Women With HIV - Medscape

    MedscapeOnce-Daily Dolutegravir Regimen Assists Women With HIVMedscape'If we look at all of the dolutegravir studies — whether they are comparing dolutegravir with darunavir or efavirenz — we see superiority in the dolutegravir arm.

  • Enanta Announces the U.S. Food and Drug Administration has approved AbbVie's New, Once-Daily VIEKIRA XR ... - Business Wire (press release)

    Enanta Announces the U.

    Copyright © cheapgenerics24.com